| A critical analysis of test-retest reliability in instrument validation studies of cancer patients under palliative care: a systematic review CE Paiva, EM Barroso, EC Carneseca, C de Pádua Souza, ... BMC medical research methodology 14, 1-10, 2014 | 183 | 2014 |
| Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry GC Fernandes, RAD Michelli, HCR Galvão, AE Paula, R Pereira, ... Oncotarget 7 (49), 80465, 2016 | 92 | 2016 |
| The germline mutational landscape of BRCA1 and BRCA2 in Brazil EI Palmero, DM Carraro, B Alemar, MAM Moreira, A Ribeiro-dos-Santos, ... Scientific reports 8 (1), 9188, 2018 | 85 | 2018 |
| Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer AJA Freitas, RL Causin, MB Varuzza, S Calfa, CMT Hidalgo Filho, ... International journal of molecular sciences 23 (17), 9952, 2022 | 76 | 2022 |
| Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma NC Cinegaglia, SCS Andrade, T Tokar, M Pinheiro, FE Severino, ... Oncotarget 7 (20), 28920, 2016 | 63 | 2016 |
| Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer PS Felicio, RS Grasel, N Campacci, AE de Paula, HCR Galvão, ... Human mutation 42 (3), 290-299, 2021 | 61 | 2021 |
| Efficacy of neratinib plus capecitabine in the subgroup of patients with central nervous system involvement from the NALA trial SA Hurvitz, C Saura, M Oliveira, ME Trudeau, B Moy, S Delaloge, ... The oncologist 26 (8), e1327-e1338, 2021 | 57 | 2021 |
| A pilot study addressing the impact of religious practice on quality of life of breast cancer patients during chemotherapy CE Paiva, BSR Paiva, RA de Castro, CP Souza, YC de Paiva Maia, ... Journal of Religion and Health 52, 184-193, 2013 | 44 | 2013 |
| Identification of cell‐free circulating MicroRNAs for the detection of early breast cancer and molecular subtyping KCB Souza, AF Evangelista, LF Leal, CP Souza, RA Vieira, RL Causin, ... Journal of Oncology 2019 (1), 8393769, 2019 | 39 | 2019 |
| What are the personal and professional characteristics that distinguish the researchers who publish in high-and low-impact journals? A multi-national web-based survey CE Paiva, RLC Araujo, BSR Paiva, C de Pádua Souza, FM Cárcano, ... ecancermedicalscience 11, 2017 | 36 | 2017 |
| Inflammatory breast cancer: clinical implications of genomic alterations and mutational profiling FLC Faldoni, RAR Villacis, LM Canto, CE Fonseca-Alves, SS Cury, ... Cancers 12 (10), 2816, 2020 | 23 | 2020 |
| Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital EI Palmero, HCR Galvão, GC Fernandes, AE Paula, JC Oliveira, ... Genetics and Molecular Biology 39 (2), 168-177, 2016 | 23 | 2016 |
| Molecular biomarkers predict pathological complete response of neoadjuvant chemotherapy in breast cancer patients AJA Freitas, RL Causin, MB Varuzza, CMT Hidalgo Filho, VD Silva, ... Cancers 13 (21), 5477, 2021 | 22 | 2021 |
| Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line MN Rosa, AF Evangelista, LF Leal, CM De Oliveira, VAO Silva, ... Scientific reports 9 (1), 1913, 2019 | 19 | 2019 |
| Does neoadjuvant therapy for pancreatic head adenocarcinoma increase postoperative morbidity? A systematic review of the literature with meta‐analysis RLC Araujo, RO Silva, C de Padua Souza, JM Milani, F Huguet, ... Journal of Surgical Oncology 121 (5), 881-892, 2020 | 18 | 2020 |
| BR-BCSC signature: the cancer stem cell profile enriched in brain metastases that predicts a worse prognosis in lymph node-positive breast cancer MR Dionísio, AF Vieira, R Carvalho, I Conde, M Oliveira, M Gomes, ... Cells 9 (11), 2442, 2020 | 17 | 2020 |
| The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers CE Paiva, FAF Siquelli, HA Santos, MM Costa, DR Massaro, DC Lacerda, ... BMC cancer 15, 1-6, 2015 | 17 | 2015 |
| Socioeconomic, clinical, and molecular features of breast cancer influence overall survival of Latin American women LM de Almeida, S Cortes, M Vilensky, O Valenzuela, L Cortes-Sanabria, ... Frontiers in oncology 12, 845527, 2022 | 14 | 2022 |
| Ovarian Sertoli-Leydig cell tumors: Epidemiological, clinical and prognostic factors BGR Castro, CP Souza, CEMC Andrade, MA Vieira, DAP Andrade, ... Revista Brasileira de Ginecologia e Obstetrícia 41 (07), 440-448, 2019 | 13 | 2019 |
| Using co-segregation and loss of heterozygosity analysis to define the pathogenicity of unclassified variants in hereditary breast cancer patients RS Grasel, PS Felicio, AE De Paula, N Campacci, FANDO Garcia, ... Frontiers in Oncology 10, 571330, 2020 | 11 | 2020 |
Márcia M C Marques Silveirapesquisadora e professora em oncologia molecularE-mail confirmado em usp.br
